| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-15 18:25:14 UTC |
|---|
| Update Date | 2021-09-14 15:48:16 UTC |
|---|
| HMDB ID | HMDB0060641 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Lamivudine-monophosphate |
|---|
| Description | Lamivudine-monophosphate belongs to the class of organic compounds known as nucleoside and nucleotide analogues. These are analogues of nucleosides and nucleotides. These include phosphonated nucleosides, C-glycosylated nucleoside bases, analogues where the sugar unit is a pyranose, and carbocyclic nucleosides, among others. Lamivudine-monophosphate is an extremely weak basic (essentially neutral) compound (based on its pKa). Within humans, lamivudine-monophosphate participates in a number of enzymatic reactions. In particular, lamivudine-monophosphate and uridine 5'-diphosphate can be converted into lamivudine and uridine triphosphate through the action of the enzyme 5'(3')-deoxyribonucleotidase, cytosolic type. In addition, lamivudine-monophosphate can be converted into lamivudine-diphosphate; which is mediated by the enzyme UMP-CMP kinase. Lamivudine-monophosphate is a metabolite of lamivudine. In humans, lamivudine-monophosphate is involved in lamivudine metabolism pathway. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine (2',3'-dideoxy-3'-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). |
|---|
| Structure | NC1=NC(=O)N(C=C1)C1CSC(COP(O)(O)=O)O1 InChI=1S/C8H12N3O6PS/c9-5-1-2-11(8(12)10-5)6-4-19-7(17-6)3-16-18(13,14)15/h1-2,6-7H,3-4H2,(H2,9,10,12)(H2,13,14,15) |
|---|
| Synonyms | | Value | Source |
|---|
| Lamivudine-monophosphoric acid | Generator |
|
|---|
| Chemical Formula | C8H12N3O6PS |
|---|
| Average Molecular Weight | 309.236 |
|---|
| Monoisotopic Molecular Weight | 309.018442333 |
|---|
| IUPAC Name | {[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-1,3-oxathiolan-2-yl]methoxy}phosphonic acid |
|---|
| Traditional Name | [5-(4-amino-2-oxopyrimidin-1-yl)-1,3-oxathiolan-2-yl]methoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC1=NC(=O)N(C=C1)C1CSC(COP(O)(O)=O)O1 |
|---|
| InChI Identifier | InChI=1S/C8H12N3O6PS/c9-5-1-2-11(8(12)10-5)6-4-19-7(17-6)3-16-18(13,14)15/h1-2,6-7H,3-4H2,(H2,9,10,12)(H2,13,14,15) |
|---|
| InChI Key | WUMZLKDCOINBEA-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as nucleoside and nucleotide analogues. These are analogues of nucleosides and nucleotides. These include phosphonated nucleosides, C-glycosylated nucleoside bases, analogues where the sugar unit is a pyranose, and carbocyclic nucleosides, among others. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Nucleoside and nucleotide analogues |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Nucleoside and nucleotide analogues |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hydroxypyrimidine
- Monoalkyl phosphate
- Hydropyrimidine
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Pyrimidine
- Monothioacetal
- Oxathiolane
- Heteroaromatic compound
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.41 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.2335 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.42 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 417.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 234.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 56.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 151.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 46.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 297.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 267.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 743.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 590.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 52.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 571.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 152.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 175.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 642.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 361.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 307.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Lamivudine-monophosphate,1TMS,isomer #1 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 2907.7 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,1TMS,isomer #1 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 2750.6 | Standard non polar | 33892256 | | Lamivudine-monophosphate,1TMS,isomer #1 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 4601.4 | Standard polar | 33892256 | | Lamivudine-monophosphate,1TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 2940.0 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,1TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 2807.8 | Standard non polar | 33892256 | | Lamivudine-monophosphate,1TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 4866.7 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C | 2887.9 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C | 2799.2 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C | 4082.1 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C)O2)C=C1 | 2957.9 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C)O2)C=C1 | 2874.2 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C)O2)C=C1 | 4088.9 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #3 | C[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C | 2916.1 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #3 | C[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C | 2941.4 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TMS,isomer #3 | C[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C | 4412.8 | Standard polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O2)C=C1 | 2948.9 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O2)C=C1 | 2926.5 | Standard non polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O2)C=C1 | 3595.6 | Standard polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #2 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1 | 2927.6 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #2 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1 | 2968.2 | Standard non polar | 33892256 | | Lamivudine-monophosphate,3TMS,isomer #2 | C[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1 | 3734.4 | Standard polar | 33892256 | | Lamivudine-monophosphate,4TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1)O[Si](C)(C)C | 2925.4 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,4TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1)O[Si](C)(C)C | 3011.6 | Standard non polar | 33892256 | | Lamivudine-monophosphate,4TMS,isomer #1 | C[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CS1)O[Si](C)(C)C | 3297.8 | Standard polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 3140.3 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 2979.1 | Standard non polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N)=NC2=O)CS1 | 4634.6 | Standard polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 3187.6 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 3025.1 | Standard non polar | 33892256 | | Lamivudine-monophosphate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1 | 4784.5 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 3334.6 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 3207.5 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 4152.7 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 3398.0 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 3294.7 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 4151.0 | Standard polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C(C)(C)C | 3344.4 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C(C)(C)C | 3364.6 | Standard non polar | 33892256 | | Lamivudine-monophosphate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1)[Si](C)(C)C(C)(C)C | 4333.1 | Standard polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 3571.8 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 3503.2 | Standard non polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CSC(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O2)C=C1 | 3811.0 | Standard polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1 | 3534.2 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1 | 3566.6 | Standard non polar | 33892256 | | Lamivudine-monophosphate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OP(=O)(O)OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1 | 3847.0 | Standard polar | 33892256 | | Lamivudine-monophosphate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 3696.0 | Semi standard non polar | 33892256 | | Lamivudine-monophosphate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 3715.6 | Standard non polar | 33892256 | | Lamivudine-monophosphate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OP(=O)(OCC1OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CS1)O[Si](C)(C)C(C)(C)C | 3571.9 | Standard polar | 33892256 |
|
|---|